Autek China (300595) Stock Overview
Provides eye health and myopia prevention, and control technology and services in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 300595 from our risk checks.
300595 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Autek China Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.79 |
| 52 Week High | CN¥24.86 |
| 52 Week Low | CN¥13.03 |
| Beta | 0.89 |
| 1 Month Change | 4.64% |
| 3 Month Change | 8.45% |
| 1 Year Change | -4.07% |
| 3 Year Change | -70.04% |
| 5 Year Change | -66.08% |
| Change since IPO | 463.96% |
Recent News & Updates
Recent updates
Earnings Miss: Autek China Inc. Missed EPS By 18% And Analysts Are Revising Their Forecasts
Apr 01
Here's What's Concerning About Autek China's (SZSE:300595) Returns On Capital
Mar 19Is There Now An Opportunity In Autek China Inc. (SZSE:300595)?
Feb 20Why Investors Shouldn't Be Surprised By Autek China Inc.'s (SZSE:300595) Low P/E
Feb 06Is Autek China (SZSE:300595) A Risky Investment?
Jan 07A Look At The Fair Value Of Autek China Inc. (SZSE:300595)
Dec 24Is Autek China Inc. (SZSE:300595) Potentially Undervalued?
Nov 11Autek China (SZSE:300595) Might Be Having Difficulty Using Its Capital Effectively
Oct 14Autek China Inc.'s (SZSE:300595) Shares Climb 44% But Its Business Is Yet to Catch Up
Sep 30Autek China Inc. (SZSE:300595) Shares Could Be 49% Below Their Intrinsic Value Estimate
Sep 01Little Excitement Around Autek China Inc.'s (SZSE:300595) Earnings
Aug 14Be Wary Of Autek China (SZSE:300595) And Its Returns On Capital
Jul 04Autek China (SZSE:300595) Has Announced That It Will Be Increasing Its Dividend To CN¥0.223
May 14We Think Autek China (SZSE:300595) Can Manage Its Debt With Ease
Apr 16An Intrinsic Calculation For Autek China Inc. (SZSE:300595) Suggests It's 28% Undervalued
Mar 22Autek China Inc.'s (SZSE:300595) 25% Price Boost Is Out Of Tune With Earnings
Mar 04There Are Reasons To Feel Uneasy About Autek China's (SZSE:300595) Returns On Capital
Mar 01Shareholder Returns
| 300595 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 1.0% | 1.0% | 0.6% |
| 1Y | -4.1% | 1.9% | 25.3% |
Return vs Industry: 300595 underperformed the CN Medical Equipment industry which returned 1.9% over the past year.
Return vs Market: 300595 underperformed the CN Market which returned 25.3% over the past year.
Price Volatility
| 300595 volatility | |
|---|---|
| 300595 Average Weekly Movement | 2.4% |
| Medical Equipment Industry Average Movement | 4.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in CN Market | 8.6% |
| 10% least volatile stocks in CN Market | 2.8% |
Stable Share Price: 300595 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300595's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 3,580 | Yuequn Tao | www.orthok.cn |
Autek China Inc. provides eye health and myopia prevention, and control technology and services in China. The company operates through Ophthalmology Services; and Products segments. It also offers ophthalmic and optometry medical devices.
Autek China Inc. Fundamentals Summary
| 300595 fundamental statistics | |
|---|---|
| Market cap | CN¥13.94b |
| Earnings (TTM) | CN¥539.56m |
| Revenue (TTM) | CN¥1.83b |
Is 300595 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300595 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.83b |
| Cost of Revenue | CN¥489.24m |
| Gross Profit | CN¥1.34b |
| Other Expenses | CN¥798.50m |
| Earnings | CN¥539.56m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 23, 2025
| Earnings per share (EPS) | 0.60 |
| Gross Margin | 73.23% |
| Net Profit Margin | 29.53% |
| Debt/Equity Ratio | 0.3% |
How did 300595 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/17 08:53 |
| End of Day Share Price | 2025/07/17 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Autek China Inc. is covered by 12 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Li | BofA Global Research |
| Yichi Zhang | China International Capital Corporation Limited |
| Bin Wu | China Merchants Securities Co. Ltd. |